IVP · As filed with the SEC

Inspire Veterinary Partners cash flow statement, by quarter

The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Unaudited Condensed Consolidated Statements of Cash Flows · USD

USD	Q3 2025^† 3 months ended Sep 30, 2025	Q2 2025^† 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024	3 months ended Jun 30, 2024^† 3 months ended Jun 30, 2024	Q1 2024 3 months ended Mar 31, 2024	Q4 2023^† 3 months ended Dec 31, 2023
Cash flows from operating activities:
Net loss	(2,526,274)^†	(3,034,568)^†	(2,415,036)	(3,966,722)^†	(3,489,326)^†	(3,386,421)^†	(3,421,792)	(4,142,141)^†
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	330,498^†	258,403^†	275,392	309,248^†	340,167^†	340,926^†	347,382	336,715^†
Amortization of debt issuance costs	8,969^†	5,753^†	4,455	0^†	0^†	0^†	15,825	0^†
Amortization of debt discount	386,325^†	279,854^†	261,766	146,214^†	1,144,456^†	605,611^†	379,313	213,619^†
Amortization of operating right of use assets	53,418^†	53,417^†	77,723	60,706^†	2,368^†	212,973^†	53,831	45,512^†
Stock-based compensation	0^†	—	—	0^†	—	—	—	—
Issuance of warrants to CEO	—	—	—	—	—	—	—	0^†
Issuance of class A common stock for services	454,600^†	—	—	90,000^†	0^†	0^†	286,696	200,000^†
Debt extinguishment loss	—	—	—	—	—	—	—	0^†
Loss on debt modification	—	—	—	546,356^†	0^†	859,584^†	728,278	910,949^†
Beneficial conversion feature	—	—	—	—	—	—	—	0^†
Issuance of class A common stock in connection with general release agreement	—	—	—	0^†	0^†	0^†	20,000	—
Issuance of Class A common stock and pre-funded warrants in connection with commitment shares	—	—	—	0^†	0^†	0^†	600,000	—
Beneficial conversion feature	—	—	—	—	—	—	—	0^†
Gain on disposal of business	—	—	—	0^†	—	—	—	—
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	154,930^†	(179,258)^†	36,299	74,876^†	(75,831)^†	301,768^†	(312,915)	89,545^†
Due from former owners	—	—	—	0^†	0^†	0^†	32,519	(32,519)^†
Inventory	(20,623)^†	38,161^†	41,498	46,945^†	(31,446)^†	(28,933)^†	25,852	183,206^†
Prepaid expenses and other current assets	128,592^†	170,040^†	258,769	2,147,915^†	(1,510,132)^†	451,072^†	(1,642,552)	118,710^†
Other assets	—	—	—	(28,882)^†	48,874^†	0^†	(61,094)	745^†
Accounts payable	(175,173)^†	105,447^†	(209,512)	(94,079)^†	(1,644,384)^†	196,207^†	315,165	905,142^†
Accrued expenses	(43,424)^†	370,053^†	357,541	(19,348)^†	(656,938)^†	485,849^†	(403,107)	310,746^†
Cumulative Series A preferred stock dividends payable	—	—	—	0^†	0^†	0^†	(92,322)	—
Refundable income tax	—	—	—	0^†	0^†	—	—	0^†
Operating lease liabilities	(40,303)^†	(39,371)^†	(63,192)	(47,420)^†	6,567^†	(40,715)^†	(40,108)	(34,629)^†
Net cash used in operating activities	(1,282,695)^†	(898,284)^†	(1,374,297)	(677,527)^†	(6,309,027)^†	149,717^†	(3,169,029)	(754,782)^†
Cash flows from investing activities:
Purchase of property and equipment	(43,461)^†	(12,579)^†	(20,275)	(31,828)^†	(25,519)^†	(23,691)^†	(156,945)	(23,647)^†
Net cash used in investing activities	(43,461)^†	(1,862,579)^†	(20,275)	(31,828)^†	(25,519)^†	(23,691)^†	(156,945)	(1,505,431)^†
Cash flows from financing activities:
Proceeds from issuance of class A common stock and warrants, net of issuance costs	0^†	140,000^†	2,145,521	(3,375,458)^†	—	—	3,375,458	0^†
Proceeds from issuance of class A common stock and pre-funded warrants, net of issuance costs	0^†	(140,000)^†	1,711,466	(3,608,419)^†	5,460,000^†	0^†	—	—
Net proceeds from loans payable	0^†	—	—	513,650^†	0^†	918,750^†	549,185	531,071^†
Repayments on loans payable	(942,000)^†	(968,460)^†	(863,940)	(1,197,943)^†	(1,475,377)^†	(1,408,087)^†	(1,032,540)	(817,514)^†
Proceeds from issuance of convertible series A preferred stock	—	—	—	0^†	0^†	0^†	200,000	—
Proceeds from convertible notes payable	0^†	—	—	—	0^†	500,000^†	—	0^†
Proceeds from notes payable, net of discount	0^†	—	—	0^†	—	—	500,000	—
Payments on convertible note payable	—	—	—	(44,118)^†	—	—	—	—
Repayment of notes payable	(271,703)^†	(266,753)^†	(464,132)	(421,324)^†	(226,536)^†	(198,108)^†	(276,013)	969,231^†
Proceeds from exercise of warrants	—	—	—	500,000^†	—	—	—	—
Proceeds from issuance of promissory note	500,000^†	—	—	—	—	—	—	—
Repayment of convertible debentures	—	—	—	0^†	0^†	0^†	(100,000)	0^†
Net cash provided by financing activities	1,508,960^†	1,296,272^†	2,528,915	551,846^†	7,008,087^†	(187,445)^†	3,216,090	682,789^†
Net increase (decrease) in Cash, cash equivalents and restricted cash	182,804^†	(1,464,591)^†	1,134,343	(157,509)^†	673,541^†	(61,419)^†	(109,884)	(1,577,424)^†
Cash, cash equivalents and restricted cash, beginning of period	393,442	1,858,033	723,690	881,199	207,658	269,077	378,961	1,956,385
Cash, cash equivalents and restricted cash, end of period	576,246	393,442	1,858,033	723,690	881,199	207,658	269,077	378,961
Supplemental Disclosure of Cash Flow Information
Interest payments during the year	559,111^†	(725,533)^†	1,552,313	0^†	0^†	1,363,361^†	1,316,378	1,127,426^†
Income tax refund	—	—	151,796	0^†	0^†	—	—	—
Noncash investing and financing activity
Series A Preferred Stock Dividend	—	—	—	0^†	—	—	212,270	137,417^†
Issuance of common stock in connection with business acquisition	0^†	—	—	—	—	—	—	—
Issuance of convertible series A preferred stock due to conversion of bridge notes	—	—	—	—	—	—	—	0^†
Issuance of class A common stock due to conversion of convertible debentures	—	—	—	—	—	—	—	(1)^†
Issuance of convertible series A preferred stock due to conversion of bridge note	—	—	—	—	—	—	—	0^†
Issuance of class A common stock due to conversion of convertible debentures	—	—	—	—	—	—	—	(1)^†
Series A Preferred Stock Dividend	—	—	—	—	0^†	(50,395)^†	—	—
Issuance of class A common stock for conversion of convertible notes payable	—	—	—	707,143^†	—	—	—	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.